U.S. market Closed. Opens in 2 hours 56 minutes

DBTX | Decibel Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2022-12-312021-12-312020-12-312019-12-312018-12-31
RevenueN/AN/AN/AN/AN/A
Cost of RevenueN/AN/AN/AN/AN/A
Gross ProfitN/AN/AN/AN/AN/A
Operating Expenses63.96M50.23M39.56M44.08M37.86M
Selling, General & Admin23.63M20.38M14.24M14.68M11.69M
Research & Development40.33M29.85M25.32M29.41M26.17M
Other Operating ExpensesN/A12.00K171.00KN/AN/A
Operating Income-63.96M-50.23M-39.56M-44.08M-37.86M
Other Expenses / Income1.19M205.00K226.00K1.41M1.70M
Before Tax Income-62.77M-50.03M-39.34M-42.67M-36.16M
Income Tax Expenses240.00K1.80M-1.70M-1.41M1.70M
Net Income-63.01M-51.82M-37.64M-41.26M-36.16M
Interest Expenses1.19MN/AN/AN/AN/A
Basic Shares Outstanding24.96M21.73M23.12M7.36M7.26M
Diluted Shares Outstanding24.96M21.73M23.12M7.36M7.26M
EBITDA-62.49M-48.82M-39.56M-42.31M-36.38M
EBITDA Margin0.00%0.00%0.00%0.00%0.00%
EBIT-61.57M-50.03M-39.34M-42.67M-34.47M
EBIT Margin0.00%0.00%0.00%0.00%0.00%
Financial Year End2022-12-312021-12-312020-12-312019-12-312018-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙